Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Surgery for Locally Unresectable Pancreatic Cancer
A clinical trial sponsored by Azienda Ospedaliera di Padova is currently recruiting to evaluate surgery for locally unresectable locally adv…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
This clinical trial update reports on evaluating an early radiomic signature in patients with metastatic pancreatic adenocarcinoma treated w…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Early Recurrence After Surgery for Pancreatic Cancer
An ongoing ClinicalTrials.gov study is examining early recurrence after pancreatic cancer surgery (pancreatic ductal adenocarcinoma) and is …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer [NA]
An update on the DISSECT study evaluating peri-adventitial SMA dissection during pancreaticoduodenectomy for resectable pancreatic cancer. T…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating zolbetuximab in combination with chemotherapy for adults with metastatic pancreatic adenocarcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus anakinra for pancreatic adenocarcinoma is currently recruiting. Sponsored by Baylor Rese…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating a recombinant EphB4-HSA fusion protein in combination with standard chemotherapy for advanced or metastatic solid t…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating immunotherapy with irreversible electroporation for advanced pancreatic adenocarcinoma. Recruitment is ong…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the combination of chemotherapy and irreversible electroporation for advance…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
A clinical trial update describing an imaging and biomarker study for early detection of pancreatic cancer in patients with intraductal papi…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma [NA]
A ClinicalTrials.gov listing for a study comparing preoperative fractionated radiation therapy versus stereotactic body radiation therapy in…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating radiation therapy in combination with durvalumab for pancreatic adenocarcinoma; the study is cu…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer [Phase 2]
Phase 2 neoadjuvant trial testing the combination of two approved chemotherapy drugs with radiation before surgery for localized pancreatic …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies [Phase 1]
A Phase 1 clinical trial update evaluating the safety of a quadruple chemotherapy combination (irinotecan with 5-FU/leucovorin, oxaliplatin,…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) [Phase 1]
This Phase 1 clinical trial update describes a study of 9-ING-41 combined with retifanlimab and a modified FOLFIRINOX regimen in patients wi…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula [Phase 1, Phase 2]
A clinical trial update indicates that total pancreatectomy with islet autotransplantation (TPIAT) is being evaluated in Phase 1/2 for resec…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Patient-derived Organoids Drug Screen in Pancreatic Cancer [NA]
The study completed a patient-derived pancreatic tumor organoids drug-screen to evaluate potential drug responses.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy [Phase 2]
This clinical trial update describes a Phase 2 study evaluating maintenance Niraparib plus Ipilimumab in patients with metastatic pancreatic…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors [Phase 1]
Phase 1 first-in-human trial evaluating OKN4395 in combination with pembrolizumab in patients with solid tumors is currently recruiting. The…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: The Future Management of Patients With Neoplasms of the Gastro-intestinal Tract [NA]
This clinical trial update describes a study on the future management of gastrointestinal tract cancers, including pancreatic adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer [Phase 2]
A Phase 2 trial evaluating a four-drug regimen (nab-paclitaxel, gemcitabine, cisplatin, and hydroxychloroquine) in untreated pancreatic aden…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Genetic Testing Decision Aid [NA]
This clinical trial update reports a genetic testing decision aid study sponsored by Massachusetts General Hospital. It targets patients wit…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma [NA]
A clinical trial is evaluating stereotactic body radiation therapy for patients with non-metastasized unresectable pancreatic adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency [Phase 2, Phase 3]
This update indicates that cisplatin is being studied in patients with pancreatic adenocarcinoma who have homologous recombination deficienc…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial investigating the addition of radiotherapy to the modified FOLFIRINOX chemotherapy regimen in CA19-9-normal advanced pancrea…